Skip to main content
Download PDF

Serum hsCRP in early pregnancy and preterm delivery in twin gestations: a prospective cohort study

BMC Pregnancy and Childbirth volume 23, Article number: 123 (2023) Cite this article

Abstract

Background

Systemic inflammation during pregnancy may be associated with preterm delivery (PTD), but data for twin gestations are lacking. The aim of this study was to examine the association of serum high-sensitivity C-reactive protein (hsCRP), a marker of inflammation, in early pregnancy of twin gestations with risk of PTD, including spontaneous (sPTD) and medical-induced preterm delivery (mPTD).

Methods

A prospective cohort study involved 618 twin gestations was conducted in a tertiary hospital in Beijing, from 2017 to 2020. Serum samples collected in early pregnancy were analyzed for hsCRP using particle-enhanced immunoturbidimetric method. Unadjusted and adjusted geometric means (GM) of hsCRP were estimated using linear regression, and compared between PTD before 37 weeks of gestation and term delivery at 37 or more weeks of gestation using Mann–Whitney rank sum test. The association between hsCRP tertiles and PTDs was estimated using logistic regression, and further converted overestimated odds ratios into relative risks (RR).

Results

A total of 302 (48.87%) women were classified as PTD, with 166 sPTD and 136 mPTD. The adjusted GM of serum hsCRP was higher in PTDs (2.13 mg/L, 95% confidence interval [CI] 2.09 –2.16) compared to term deliveries (1.84 mg/L, 95% CI 1.80 –1.88) (P < 0.001). Compared with the lowest tertile of hsCRP, the highest tertile was associated with increased risk of PTD (adjusted relative risks [ARR] 1.42; 95% CI: 1.08–1.78). Among twin pregnancies, the adjusted association between high values of serum hsCRP in early pregnancy and preterm delivery was only observed in the subgroup of spontaneous preterm deliveries (ARR 1.49, 95%CI:1.08–1.93).

Conclusions

Elevated hsCRP in early pregnancy was associated with increased risk of PTD, particular the risk of sPTD in twin gestations.

Peer Review reports

Background

High infant morbidity and mortality in twin gestations are predominantly related to preterm delivery (PTD) [1, 2]. Among twin pregnancies, the risk of PTD is up to 56.6% [3], which still rising in most nations [4, 5], making a major concern in modern obstetrics.

PTD can be categorized into three subtypes including spontaneous PTD (sPTD), preterm premature rupture of membranes (PROM), and medical-induced PTD (mPTD) [4]. PROM, as a precursor, is commonly incorporated into sPTD [6]. sPTD accounts for 60–70% of PTD, and the remaining 30–40% was mPTD [4, 7]. sPTD is considered as a syndrome caused by multiple mechanisms such as inflammation and uteroplacental ischaemia [7], and common indications for mPTD include preeclampsia and fetal stress, et al. [8]. Additionally, for twin gestations, monochorionic pregnancy is recommended to be electively induced ≤ 36 weeks of gestation to decrease the potential risks [9].

Systemic inflammation stimulates the secretion of cytokines from the pregnant tissues and further the action in cascades, contributing to multiple pathways of sPTD [4, 7]. C-reactive protein (CRP) is a typical biomarker in response to inflammatory stimulation [10]. And high-sensitive CRP (hsCRP), with lower limit of detection, can reflect low-grade inflammation. Previous studies in singleton indicated that elevated maternal serum CRP or hsCRP was associated with increased risk of sPTD [11,12,13]. However, related data is lacking for twins. Only two studies on twins reported a positive association of Interleukin-8, another inflammatory indicator, in mid-pregnancy with sPTD [14, 15].

The objective of this prospective cohort study was to test the hypothesis that hsCRP in early pregnancy may increase the risk of PTD in twin gestations.

Methods

Participants and data collection

A prospective multicenter University Hospital Advanced Age Pregnant (UNIHOPE) cohort was conducted from 2017 to 2020 in China [16]. In the study, data on twin gestations collected in a tertiary hospital in Beijing was used.

Pregnant women with mental disorders or who were unable to provide informed consent were not enrolled. Potential pregnant women with twin gestations before 12 GW were consecutively enrolled by trained investigators at registration in hospitals during study period. In this study, eligible criteria of twin pregnant women included (a) receiving prenatal health care and admitting to delivery at the tertiary hospital, (b) having examined hsCRP in early pregnancy, (c) delivering at least one live birth. Women with severe pathological conditions, such as Twin-Twin Transfusion Syndrome or Twin Reversed Arterial Perfusion related to monochorionic pregnancies were excluded.

At enrollment, we collected information including maternal age, education level (middle school or less, high school, postgraduate or above), couple income per year (< 12, 12 ~ , 20 ~ , 30 ~ ten thousand yuan), prepregnant BMI (< 18.5, 18.5 ~ , 24 ~ kg/m2), parity (0,1 ~), active or passive smoke, alcohol, date of last menstrual period (LMP), anti-inflammatory drugs use, progestogens use, type of conception (spontaneous, assisted reproductive technology (ART)), type of chorionic membrane, vaginosis or periodontitis. Threatened premature labor (TPL) and PROM were obtained in both the second and third trimesters. Spontaneous abortion, stillbirth, and fetal reduction operation were also assessed as fetal loss before delivery. After enrollment, women were followed up at 24–28 GW, 28–32 GW, and during delivery in the hospitals.

Sample collection and hsCRP measurement

The blood samples from women were drawn during 5–18 GW and serum was separated and examined within 2 h after collection. All standardized procedures were conducted by clinical laboratory staffs in the tertiary hospital. Maternal serum hsCRP concentrations were determined by a validated high-sensitivity particle-enhanced immunoturbidimetric assay (DiaSys Diagnostic Systems, Holzheim, Germany) on the Beckman-Coulter AU5800 analyzer (CA, USA). Coefficients of variation were 2.6% (intraassay) and 1.0% (interassay), with a limit of detection (LOD) as 0.05 mg/L. The concentration of hsCRP (3 of those assayed) below the LOD were imputed using the half LOD (0.025 mg/L). The outlier of hsCRP was identified as a value > 3 IQRs from the 25th or 75th percentiles.

PTD definition

The primary outcome was overall PTD, which was defined as delivery before 37 GW [17]. PTD was further divided into sPTD and mPTD. mPTD was defined as PTD simultaneously with preeclampsia (diagnosed by professional obstetricians with maternal hypertension and/or proteinuria), fetal stress (at least one of twin was evaluated by professional obstetricians mainly with antenatal cardiotocography), fetal growth restriction (at least one of twin was diagnosed by professional ultrasonologist), or antenatal hemorrhage (mainly caused by placenta previa or placental abruption) [18]. The remaining of overall PTD was defined as sPTD, including PTD initiated by spontaneous labor or preterm premature rupture of membranes. For monochorionic pregnancies, elective cesarean preterm deliveries without medical necessity were also considered as sPTD.

Statistical analyses

Each twin-pregnant woman rather than every fetus was the study unit. Using the Shapiro–Wilk Normality Test, serum hsCRP had non-normal distribution (P < 0.001), with a skewness of 7.28 and a kurtosis of 77.97. Thus, geometric mean (GM) was used to describe serum hsCRP. To calculate GM, hsCRP was log transformed and then back transformed into the initial scale. GM (95% CI) or frequency (percent) were used to characterize descriptive data. Kruskal–Wallis test and post hoc Wilcoxon tests with the Bonferroni method for multiple comparisons were used to examine the discrepancies for continuous variables. Chi-square test and multiple comparisons with the Bonferroni method were conducted for testing the differences of categorical variables.

Univariable and multivariable linear regression models on logarithm transformed hsCRP were conducted to estimate unadjusted and adjusted least squares GM. Mann–Whitney rank sum test was used to compare the GMs between PTDs and term delivery.

When association analysis was performed, hsCRP, as exposure, was conducted as a tertile variable because the highest tertile was close to the abnormal range clinically. Univariable and multivariable logistic regression models were used to calculate unadjusted and adjusted odds ratio [OR] and 95%CI for PTDs among hsCRP tertiles, with the lowest tertile serving as the reference. Because of the high PTD rates among twin gestations, ORs were subsequently converted to relative risks [RR] [19]. In multivariable models, covariates included maternal age, couple income per year, prepregnant BMI, GW at blood drawing, and type of conception were adjusted.

To determine the robustness of the association between hsCRP and PTDs, subgroup analyses stratified by baseline characteristics were performed. In addition, sensitivity analyses were performed by excluding women with vaginosis (n = 12) or periodontitis (n = 16) at enrollment, concerning that vaginosis [20] or periodontitis [21] may contribute to sPTD.

Based on the cohort study design, it was estimated that a sample of 281 twin-pregnant women would have a 90% power to identify the significant association between hsCRP and sPTD equal to or higher than 1.3, considering a 30% incidence rate among twin gestations.

All analyses were conducted using R software version 4.0.2, and all P values were two sided with the statistical significance level of 0.05.

Results

A total of 618 twin gestations were included in the study, after excluding one woman with outlier of hsCRP. The GMs of hsCRP tertiles were 0.47 (95%CI: 0.42–0.53), 1.99 (95%CI: 1.91–2.06) and 6.13 (95%CI: 5.69–6.61), respectively. Demographic and maternal characteristics of all participants are summarized by hsCRP tertiles in Table 1. Pregnant women in the highest tertile of hsCRP were more likely to be older (P = 0.011), using progestogens at baseline (P = 0.004), conceiving by ART (P = 0.008), having a higher GW at blood drawing (P = 0.005) and a lower educational level (P < 0.001), compared with those in the lowest tertile. Women with higher hsCRP levels could be seen in those whose prepregnant BMI were greater than 24 kg/m2 (44.61%, 20.10%, 11.71%; K-W test: P < 0.001), and pairwise comparisons were all statistically significant.

Table 1 Demographic and maternal characteristics of participants by hsCRP tertiles
Full size table

The range of gestational age at delivery was 26–41.5 GW, with 302 women delivered at preterm, among which 166 (54.97%) were sPTD and 136 (45.03%) were mPTD. The comparisons of crude and adjusted least squares GMs for hsCRP between PTDs and term deliveries are presented in Table 2. The crude least squares GMs for hsCRP in overall PTD (2.12 mg/L), sPTD (1.94 mg/L) and mPTD (2.22 mg/L) were consistently higher than that in term deliveries (1.51 mg/L) (all P < 0.001). After multivariable adjustment, only sPTD had a greater hsCRP levels compared to term delivery (2.20 mg/L vs. 1.84 mg/L, P < 0.001).

Table 2 Geometric means (GM) [95% CI] of hsCRP among different delivery status
Full size table

The crude and adjusted relative risk (RR) of PTDs among hsCRP tertiles referring to the lowest tertile are illustrated in Table 3. In the crude analyses, women in the highest tertile of hsCRP, had increased risks of overall PTD (RR 1.40, 95%CI: 1.10–1.74), sPTD (RR 1.36, 95%CI: 1.00–1.75), and mPTD (RR 1.46, 95%CI: 1.07–1.89), compared with those in the lowest tertile. After adjustment of maternal age, couple income per year, prepregnant BMI, GW at blood drawing and type of conception, women in the highest tertile of hsCRP still presented significant higher risks for developing overall PTD (adjusted relative risks [ARR] 1.42, 95%CI: 1.08–1.78) and sPTD (ARR 1.49, 95%CI: 1.08–1.93), but not for mPTD (ARR 1.32, 95%CI: 0.91–1.79).

Table 3 Relative risk of PTDs in association with hsCRP tertiles
Full size table

There was a subtle trend between hsCRP tertiles and sPTD, close to statistical significance (Ptrend = 0.060) after adjusting for covariates. To note, removing the serum samples of below LOD (n = 3), the linear trend between hsCRP tertiles and sPTD turned to be significant (Ptrend = 0.046), with the 1.51-fold risk (95% CI: 1.10,1.96).

To confirm the robustness of the hsCRP-sPTD association, subgroup analyses were performed (Fig. 1). The increased risk of sPTD in the highest tertile of hsCRP was consistently observed in some subgroups. Moreover, a significant interaction between hsCRP tertiles and PROM was found (P value for interaction test = 0.041), and no statistical interactions were observed for other covariates.

Fig. 1
figure 1

Subgroup analyses of hsCRP tertiles and sPTD

Full size image

Sensitivity analyses were performed to examine the confounding effects on RRs by excluding women who had vaginosis or periodontitis in early pregnancy. There was almost no change in the results: after excluding women who had vaginosis alone (ARR = 1.50, 95%CI: 1.09–1.95) or periodontitis alone (ARR = 1.45, 95%CI: 1.03–1.89), the top tertile of hsCRP still increased the risk of developing sPTD; and further excluding both, the ARR was 1.45 (95%CI: 1.04–1.97).

Discussion

From this prospective cohort study, we found that elevated hsCRP level in early pregnancy is positively associated with sPTD rather than mPTD among Chinese twin gestations. Compared with the lowest hsCRP tertile (lower than 1.26 mg/L), the highest hsCRP tertile (higher than 3.22 mg/L) increased almost 1.5-fold risk of sPTD, whether there existed vaginosis or periodontitis in early pregnancy or not. We also found that PROM appeared to be a strong positive modifier of this relationship. To the best of our knowledge, this is the first prospective cohort study specifically for twin gestations to examine the relationship of hsCRP in early pregnancy and PTD, which includes both sPTD and mPTD. Our findings fill the gap for twin gestations to support the hypothesis that early pregnancy inflammation contributes to sPTD, which has been reported in singleton pregnancies [11,12,13, 22, 23].

There are no uniform standards for normal hsCRP range for pregnant women. Due to various detection assays and mixed populations, the references differed by hospitals. In this tertiary hospital, hsCRP ≥ 3 mg/L was defined as out of normal range. The highest tertile hsCRP was > 3.22 mg/L in our study, close to the reference range. Up to date, we had not found any research on the levels of hsCRP in twin pregnancies. Studies in singleton pregnancies showed that the levels of CRP increased in the first trimester, peaked at about 20 weeks, and then decreased gradually until delivery [24]. Those serum CRP was measured by ELISA, which could not deal as well with CRP out of standard curve as the particle-enhanced immunoturbidometric method could. Assay method in our study is more sensitive, making it possible to test a lower LOD of hsCRP. Also, the median GWs of serum detection in previous studies were later than ours, as hsCRP is known to increase with increasing GW [24].

The incidence of PTD among twin gestations (48.9%) was consistent with that reported in other comparable studies in China [5] or other countries [18, 25]. In addition, the proportion of PTD subtypes in our study (55.0% sPTD and 45.0% mPTD) was also close with previous studies [5, 25]. To note, we distinguished sPTD from overall PTD. Pregnant women with medical indications who underwent an elective cesarean delivery before 37 GW were considered as mPTD [5, 25]. The incidence of PTD differed by types of chorionic membrane in twin-pregnancy. Monochorionic twins had a higher incidence of PTD than dichorionic twins [26], which was consistently observed in our study (70.0% vs 41.32%, P < 0.001).

The magnitude of the hsCRP-sPTD association in our study (ARR 1.5) was weaker than that in a singleton pregnancy study [11] (serum hsCRP cut-off values ranged from 5.6 mg/L to 7.6 mg/L; corresponding ORs ranged from 1.7 to 2.0). A cohort study from Iran conducted in 120 singleton gravidas [13] also showed that one-unit increase in early serum hsCRP increased the risk of sPTD by 2.3-fold. And other two singleton pregnancy studies even had stronger significant ORs on the hsCRP concentration over 8 mg/L (ORs: 2.6 and 2.9) [12, 22]. The positive hsCRP- sPTD association was consistently observed across various subgroups. The association was only observed in dichorionic twins but not in monochorionic twins probably because the latter were more likely to be electively induced before or at 36 GW. In addition, a majority of lower limits of 95% CIs for significant RRs in subgroup analyses were ranging from 1.01 to 1.19, indicating that the effect might be mild. However, it is worth noting that even the modest association may still be of considerable public health importance given the extremely high rates of PTD among twin gestations.

Biological plausibility for the adverse effect of hsCRP on sPTD is based on the relationship between inflammatory response and labor process [7, 27,28,29]. The current clinical consensus is that inflammation in early pregnant may result in sPTD in singleton gravida, while the most widely accepted explanation for twin gestations is uterine overdistention [7]. A recent experiment suggested that inflammation may response to uterine overdistention, which was also observed in amnion and myometrium of women with twins in vitro [30]. The evidence supported the potential relationship between inflammation and sPTD among twin gestations. On the one hand, pro-inflammatory cytokines such as IL-1, IL-6, IL-8 and tumor necrosis factor α (TNF-α) activate the uterus by stimulating prostaglandin synthesis and decreasing the response of tissue progesterone [7]; through the regulation of pro-inflammatory cytokines, hepatocytes secrete CRP in response to inflammation and then release into the systemic circulation. On the other hand, hsCRP appeared an increasing trend in early pregnancy [24], and the inflation of uterus also increased with GW. Thus, elevated hsCRP may be a potential accompanying process for uterine overdistention among twin gestations.

We did not observe any association between hsCRP and mPTD in overall and subgroup analyses. There was a dramatic difference between crude and adjusted RRs for hsCRP-mPTD association (positive to negative). In the full-adjusted models, we found that removing BMI categories made the ARR (1.45, 95% CI: 1.04–1.90) significantly stronger than that non-significant one (1.33, 95% CI: 0.91–1.79), indicating that prepregnant BMI was a potential confounding factor, attenuating the association between hsCRP and mPTD. Previous study found that overweight or obese women were more likely to trigger the hsCRP-PTD pathway [31], supporting our findings. We did not observe the association in this population, probably due to the limited sample size (only 110 women had prepregnant BMI ≥ 24 kg/m2) after stratified by PTD subtypes.

Our study has several strengths. First, well-implemented cohort follow-up visits enabled us to obtain abundant reliable information on covariates, and detailed diagnosis information made it possible for us to distinguish mPTD from sPTD. Second, replication of the association in different demographic and pregnant character settings, and in sensitive analyses enhanced the validity of results. Third, we found that PROM had a modification effect between hsCRP-sPTD association. The simultaneous presence of early elevated hsCRP and later PROM multiplied the risk of sPTD (from 1.49 to 2.80), consisting that PROM women may exist subclinical inflammation [32]. Finally, to avoid diagnostic suspicion bias, we further analyzed the incidence rate of PTD between women with and without hsCRP values, and the post hoc analysis showed that it was a random event for women to check hsCRP or not (PTD rates: 49.0% vs 55.6%, P = 0.210).

There are still some limitations in our study. There are 85.2% of participants were nulliparous women, thus caution is needed when generalizing our results to multiparous women. Among multiparous women in our study, there was only one had had a previous PTD, limiting us to assess the effect of previous PTD history on our results. In addition, each twin-pregnant woman in our study measured hsCRP mainly during first trimester, but there are no hsCRP measurements during second trimester or third trimester. Thus, we cannot examine hsCRP trend in sPTD risks throughout the entire pregnancy. Besides, information about vaginosis or periodontist was self-reported and information on cervical length status at baseline was not collected, which might introduce potential bias to our results.

Conclusion

To summarize, hsCRP was positively associated with an increased risk of sPTD among twin gestations. Our findings indicated that inflammation in early pregnancy might influence the timing of labor onset, leading sPTD. Future studies are needed to investigate the effect of a spectrum of inflammatory markers from different trimesters on the risk of PTD among twin gestations.

Availability of data and materials

The datasets generated during and analysed during the current study are not publicly available due to the personal privacy and the hospital policy, but are available from the corresponding author on reasonable request.

Abbreviations

PTD:

Preterm delivery

sPTD:

Spontaneous preterm delivery

mPTD:

Medical-induced preterm delivery

hsCRP:

High-sensitivity C- reactive protein

GW:

Gestational week

ART:

Assisted reproductive technology

TPL:

Threatened premature labor

PROM:

Premature rupture of membrane

GM:

Geometric means

RR:

Relative risk

ARR:

Adjusted relative risk

BMI:

Body mass index

References

  1. Liu L, Oza S, Hogan D, Chu Y, Perin J, Zhu J, Lawn JE, Cousens S, Mathers C, Black RE. Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet. 2016;388(10063):3027–35.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Ko HS, Wie JH, Choi SK, Park IY, Park YG, Shin JC. Multiple birth rates of Korea and fetal/neonatal/infant mortality in multiple gestation. PLoS ONE. 2018;13(8):e202318.

    Article  Google Scholar 

  3. Martin JA, Hamilton BE, Osterman MJ, Curtin SC, Matthews TJ. Births: final data for 2013. Natl Vital Stat Rep. 2015;64(1):1–65.

    PubMed  Google Scholar 

  4. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75–84.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Zou L, Wang X, Ruan Y, Li G, Chen Y, Zhang W. Preterm birth and neonatal mortality in China in 2011. Int J Gynecol Obstet. 2014;127(3):243–7.

    Article  Google Scholar 

  6. Kacerovsky M, Musilova I, Andrys C, Hornychova H, Pliskova L, Kostal M, Jacobsson B. Prelabor rupture of membranes between 34 and 37 weeks: the intraamniotic inflammatory response and neonatal outcomes. Am J Obstet Gynecol. 2014;210(4):321–5.

    Article  Google Scholar 

  7. Romero R, Dey SK, Fisher SJ. Preterm labor: One syndrome, many causes. Science. 2014;345(6198):760–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Brubaker SG, Gyamfi C. Prediction and prevention of spontaneous preterm birth in twin gestations. Semin Perinatol. 2012;36(3):190–4.

    Article  PubMed  Google Scholar 

  9. Sela HY, Flood K. Timing of planned delivery in uncomplicated monochorionic diamniotic twin pregnancies: a review of the literature. Expert Rev Obstet Gynecol. 2012;7(5):483–91.

    Article  CAS  Google Scholar 

  10. Black S, Kushner I, Samols D. C-reactive Protein. J BIOL CHEM. 2004;279(47):48487–90.

    Article  CAS  PubMed  Google Scholar 

  11. Hvilsom GB, Thorsen P, Jeune B, Bakketeig LS. C-reactive protein: a serological marker for preterm delivery? Acta Obstet Gynecol Scand. 2002;81(5):424–9.

    Article  PubMed  Google Scholar 

  12. Catov JM, Bodnar LM, Ness RB, Barron SJ, Roberts JM. Inflammation and dyslipidemia related to risk of spontaneous preterm birth. Am J Epidemiol. 2007;166(11):1312–9.

    Article  PubMed  Google Scholar 

  13. Nikbakht R, Moghadam EK, Nasirkhani Z. Maternal serum levels of C-reactive protein at early pregnancy to predict fetal growth restriction and preterm delivery: a prospective cohort study. Int J Reprod Biomed. 2020;18(3):157–64.

    PubMed  PubMed Central  Google Scholar 

  14. Rode L, Klein K, Larsen H, Holmskov A, Andreasen KR, Uldbjerg N, Ramb J, Bødker B, Skibsted L, Sperling L, et al. Cytokines and the risk of preterm delivery in twin pregnancies. Obstet Gynecol. 2012;120(1):60–8.

    Article  CAS  PubMed  Google Scholar 

  15. Wennerholm UB, Holm B, Mattsby-Baltzer I, Nielsen T, Platz-Christensen JJ, Sundell G, Hagberg H. Interleukin-1alpha, interleukin-6 and interleukin-8 in cervico/vaginal secretion for screening of preterm birth in twin gestation. Acta Obstet Gynecol Scand. 1998;77(5):508–14.

    CAS  PubMed  Google Scholar 

  16. Liu J. University Hospital Advanced Age Pregnant Cohort -Full Text View- ClinicalTrials. gov. [EB/OL]. https://clinicaltrials.gov/ct2/show/NCT03220750. Accessed 16 June 2021.

  17. Preterm birth [WHO website]. 2018. https://www.who.int/news-room/fact-sheets/detail/preterm-birth. Accessed 05 July 2021.

  18. Gardner MO, Goldenberg RL, Cliver SP, Tucker JM, Nelson KG, Copper RL. The origin and outcome of preterm twin pregnancies. Obstet Gynecol. 1995;85(4):553–7.

    Article  CAS  PubMed  Google Scholar 

  19. Zhang J, Yu KF. What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690–1.

    Article  CAS  PubMed  Google Scholar 

  20. Romero R, Chaiworapongsa T, Kuivaniemi H, Tromp G. Bacterial vaginosis, the inflammatory response and the risk of preterm birth: a role for genetic epidemiology in the prevention of preterm birth. Am J Obstet Gynecol. 2004;190(6):1509–19.

    Article  PubMed  Google Scholar 

  21. Mohr S, Amylidi-Mohr SK, Stadelmann P, Sculean A, Persson R, Eick S, Surbek DV. Systemic inflammation in pregnant women with periodontitis and preterm prelabor rupture of membranes: a prospective case-control study. Front Immunol. 2019;10:2624.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Pitiphat W, Gillman MW, Joshipura KJ, Williams PL, Douglass CW, Rich-Edwards JW. Plasma C-reactive protein in early pregnancy and preterm delivery. Am J Epidemiol. 2005;162(11):1108–13.

    Article  PubMed  Google Scholar 

  23. Park H, Park KH, Kim YM, Kook SY, Jeon SJ, Yoo H. Plasma inflammatory and immune proteins as predictors of intra-amniotic infection and spontaneous preterm delivery in women with preterm labor: a retrospective study. BMC Pregnancy Childb. 2018;18(1):146.

    Article  Google Scholar 

  24. Ferguson KK, McElrath TF, Chen YH, Mukherjee B, Meeker JD. Longitudinal profiling of inflammatory cytokines and C-reactive protein during uncomplicated and preterm pregnancy. Am J Reprod Immunol. 2014;72(3):326–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Ananth CV, Joseph KS, Demissie K, Vintzileos AM. Trends in twin preterm birth subtypes in the United States, 1989 through 2000: Impact on perinatal mortality. Am J Obstet Gynecol. 2005;193(3, Supplement):1071–6.

    Article  Google Scholar 

  26. Litwinska E, Syngelaki A, Cimpoca B, Frei L, Nicolaides KH. Outcome of twin pregnancy with two live fetuses at 11–13 weeks’ gestation. Ultrasound Obstet Gynecol. 2020;55(1):32–8.

    Article  CAS  PubMed  Google Scholar 

  27. Romero R, Espinoza J, Gonçalves LF, Kusanovic JP, Friel LA, Nien JK. Inflammation in preterm and term labour and delivery. Semin Fetal Neonatal Med. 2006;11(5):317–26.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Christiaens I, Zaragoza DB, Guilbert L, Robertson SA, Mitchell BF, Olson DM. Inflammatory processes in preterm and term parturition. J Reprod Immunol. 2008;79(1):50–7.

    Article  CAS  PubMed  Google Scholar 

  29. Aagaard-Tillery KM, Silver R, Dalton J. Immunology of normal pregnancy. Semin Fetal Neonatal Med. 2006;11(5):279–95.

    Article  PubMed  Google Scholar 

  30. Adams WK, Singh N, Mohan AR, Young RC, Ngo L, Das A, Tsai J, Bansal A, Paolella L, Herbert BR, et al. Uterine overdistention induces preterm labor mediated by inflammation: observations in pregnant women and nonhuman primates. Am J Obstet Gynecol. 2015;213(6):830–1.

    Google Scholar 

  31. Bullen BL, Jones NM, Holzman CB, Tian Y, Senagore PK, Thorsen P, Skogstrand K, Hougaard DM, Sikorskii A. C-reactive protein and preterm delivery: clues from placental findings and maternal weight. Reprod Sci (Thousand Oaks, Calif). 2013;20(6):715–22.

    Article  CAS  Google Scholar 

  32. Musilova I, Kacerovsky M, Stepan M, Bestvina T, Pliskova L, Zednikova B, Jacobsson B. Maternal serum C-reactive protein concentration and intra-amniotic inflammation in women with preterm prelabor rupture of membranes. PLoS ONE. 2017;12(8):e182731.

    Article  Google Scholar 

Download references

Acknowledgements

We are grateful to all pregnant women participated in the study, and also to all staffs assisted in the implementation of the study from Department of Obstetrics and Gynecology in Peking University Third Hospital, and Institute of Reproductive and Child Health in Peking University Medical Center.

Funding

This study is supported by the National Key Research and Development Program of China (grant number: 2016YFC1000401, 2016YFC1000408).

Author information

Authors and Affiliations

  1. Department of Social Medicine and Health Education, School of Public Health, Peking University, 38 Xueyuan Road, Haidian District, Beijing, 100191, China

    Yang-yang Chen, Yu-meng Hua & Ai-ping Liu

  2. Institute of Reproductive and Child Health, National Health Commission Key Laboratory of Reproductive Health, Peking University, Beijing, 100191, China

    Yu-bo Zhou

  3. Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, 100191, China

    Yu-bo Zhou

  4. Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, 100191, China

    Jing Yang, Peng-bo Yuan & Yuan Wei

Authors
  1. Yang-yang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yu-bo Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jing Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yu-meng Hua
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Peng-bo Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ai-ping Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yuan Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

YYC conceptualized and designed the article, contributed to data analysis and interpretation, drafted initial manuscript, and reviewed and approved the final manuscript. YBZ, APL and YW contributed to the study concept and design, interpretation of the data, and made important revision of the manuscript. JY, PBY and YMH contributed to data collection and revised the article. The author(s) read and approved the final manuscript.

Corresponding authors

Correspondence to Ai-ping Liu or Yuan Wei.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Peking University Third Hospital Medical Science Research Ethics Committee (number: IRB00006761-2016145). All participants had signed informed consent. All methods were carried out in accordance with relevant guidelines and regulations.

Consent for publication

Not applicable.

Competing interests

The authors have no competing interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, Yy., Zhou, Yb., Yang, J. et al. Serum hsCRP in early pregnancy and preterm delivery in twin gestations: a prospective cohort study. BMC Pregnancy Childbirth 23, 123 (2023). https://doi.org/10.1186/s12884-023-05445-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12884-023-05445-4

Keywords

BMC Pregnancy and Childbirth

ISSN: 1471-2393

Contact us